Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients.

Meskawi M, Sun M, Ismail S, Bianchi M, Hansen J, Tian Z, Hanna N, Trinh QD, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Mod Pathol. 2013 Aug;26(8):1144-9. doi: 10.1038/modpathol.2012.230. Epub 2013 Feb 1. Erratum in: Mod Pathol. 2013 Aug;26(8):1152.

2.

Critical analysis of a simplified Fuhrman grading scheme for prediction of cancer specific mortality in patients with clear cell renal cell carcinoma--Impact on prognosis.

Becker A, Hickmann D, Hansen J, Meyer C, Rink M, Schmid M, Eichelberg C, Strini K, Chromecki T, Jesche J, Regier M, Randazzo M, Tilki D, Ahyai S, Dahlem R, Fisch M, Zigeuner R, Chun FK.

Eur J Surg Oncol. 2016 Mar;42(3):419-25. doi: 10.1016/j.ejso.2015.09.023. Epub 2015 Oct 23.

PMID:
26520403
3.

Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.

Sun M, Bianchi M, Hansen J, Abdollah F, Trinh QD, Lughezzani G, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.

Int J Urol. 2013 Apr;20(4):372-80. doi: 10.1111/j.1442-2042.2012.03170.x. Epub 2012 Oct 8.

4.

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project..

Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22.

PMID:
22748912
5.

Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.

Meskawi M, Becker A, Bianchi M, Trinh QD, Roghmann F, Tian Z, Graefen M, Perrotte P, Karakiewicz PI, Sun M.

Int J Urol. 2014 Feb;21(2):122-8. doi: 10.1111/iju.12204. Epub 2013 Jul 2.

6.

The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.

Bigot P, Lughezzani G, Karakiewicz P, Perrotte P, Rioux-Leclercq N, Catros-Quemener V, Bouet F, Moulinoux JP, Cipolla B, Patard JJ.

J Urol. 2010 Feb;183(2):486-91. doi: 10.1016/j.juro.2009.10.012. Epub 2009 Dec 14.

PMID:
20006872
7.

Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.

Lang H, Lindner V, de Fromont M, Molinié V, Letourneux H, Meyer N, Martin M, Jacqmin D.

Cancer. 2005 Feb 1;103(3):625-9.

8.

A non-cancer-related survival benefit is associated with partial nephrectomy.

Sun M, Trinh QD, Bianchi M, Hansen J, Hanna N, Abdollah F, Shariat SF, Briganti A, Montorsi F, Perrotte P, Karakiewicz PI.

Eur Urol. 2012 Apr;61(4):725-31. doi: 10.1016/j.eururo.2011.11.047. Epub 2011 Dec 3.

PMID:
22172373
9.

Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.

Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H.

Urology. 2002 Apr;59(4):532-7.

PMID:
11927308
10.

Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?

Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T.

Urol Oncol. 2013 Jan;31(1):36-41. doi: 10.1016/j.urolonc.2010.08.026. Epub 2011 Mar 10.

PMID:
21396834
11.

Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.

Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, Bertini R, Karakiewicz PI.

Urology. 2010 Jun;75(6):1378-84. doi: 10.1016/j.urology.2009.07.1221. Epub 2009 Sep 25.

PMID:
19781745
12.

Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.

Jeldres C, Patard JJ, Capitanio U, Perrotte P, Suardi N, Crepel M, Ficarra V, Cindolo L, de La Taille A, Tostain J, Pfister C, Albouy B, Colombel M, Méjean A, Lang H, Jacqmin D, Bernhard JC, Ferrière JM, Bensalah K, Karakiewicz PI.

Urology. 2009 Jun;73(6):1300-5. doi: 10.1016/j.urology.2008.08.492. Epub 2009 Apr 18.

PMID:
19376568
13.

[Pathological prognostic indicators in renal cell carcinoma].

Rey Rey J, León Ramírez D, López García S, Fernández Vázquez P, Benavente Delgado J, Ojea Calvo A.

Actas Urol Esp. 2010 Jan;34(1):71-7. Spanish.

PMID:
20223135
14.

Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.

Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.

BJU Int. 2012 May;109(10):1457-62. doi: 10.1111/j.1464-410X.2011.10597.x. Epub 2011 Sep 20.

15.

Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.

Hansen J, Sun M, Bianchi M, Rink M, Tian Z, Hanna N, Meskawi M, Schmitges J, Shariat SF, Chun FK, Perrotte P, Graefen M, Karakiewicz PI.

Urology. 2012 Aug;80(2):347-53. doi: 10.1016/j.urology.2012.04.043. Epub 2012 Jun 13.

PMID:
22698478
16.

An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis.

Bianchi M, Becker A, Trinh QD, Abdollah F, Tian Z, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI, Sun M.

BJU Int. 2013 Jun;111(8):1184-90. doi: 10.1111/bju.12084. Epub 2013 Apr 12.

17.

Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.

Cheville JC, Lohse CM, Sukov WR, Thompson RH, Leibovich BC.

Am J Surg Pathol. 2012 Jun;36(6):851-6. doi: 10.1097/PAS.0b013e3182496895.

PMID:
22367296
18.

A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.

Paner GP, Amin MB, Alvarado-Cabrero I, Young AN, Stricker HJ, Moch H, Lyles RH.

Am J Surg Pathol. 2010 Sep;34(9):1233-40. doi: 10.1097/PAS.0b013e3181e96f2a.

PMID:
20679882
19.

[Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].

Huang JW, Zhang J, Dong BJ, Kong W, Niu SX, Chen YH, Xue W, Liu DM, Huang YR.

Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):510-3. doi: 10.3760/cma.j.issn.0253-3766.2012.07.008. Chinese.

PMID:
22967469
20.

A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.

Zini L, Perrotte P, Jeldres C, Capitanio U, Duclos A, Jolivet-Tremblay M, Arjane P, Péloquin F, Pharand D, Villers A, Montorsi F, Patard JJ, Karakiewicz PI.

BJU Int. 2009 Apr;103(7):899-904; discussion 904. doi: 10.1111/j.1464-410X.2008.08247.x. Epub 2009 Jan 20.

Supplemental Content

Support Center